Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Losartan Potassium Active Pharmaceutical Ingredient (API) Market CAGR Outlook And Future Development
The market size for losartan potassium active pharmaceutical ingredient (API) has shown substantial growth recently. This market is projected to expand from $1.85 billion in 2025 to $1.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this historical expansion include the increasing prevalence of hypertension, the expiry of branded drug patents, the growth in generic pharmaceutical manufacturing, an elevated demand for cardiovascular drugs, and the broadening of global pharmaceutical supply chains.
The losartan potassium active pharmaceutical ingredient (api) market is anticipated to demonstrate robust growth over the next few years. This market is predicted to reach a valuation of $2.54 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth during the forecast period include the rising burden of cardiovascular diseases, heightened demand from developing markets, continuous improvements in API manufacturing technologies, an increased emphasis on sustainable pharmaceutical production, and the broadening of applications in chronic kidney disease treatment. Key trends anticipated within the same period encompass a surging demand for generic losartan products, the wider implementation of continuous flow API manufacturing processes, a greater focus on developing economical antihypertensive APIs, the expanded application of losartan API in combination drug therapies, and a stronger commitment to producing regulatory-compliant APIs.
Get A Free Sample Report With In-Depth Market Insights:
Losartan Potassium Active Pharmaceutical Ingredient (API) Market Expansion Drivers: What’s Shaping Future Growth?
The increasing occurrence of hypertension is anticipated to boost the expansion of the losartan potassium active pharmaceutical ingredient (API) market in the future. Hypertension, characterized by continuously elevated blood pressure, can heighten the risk of cardiac conditions, strokes, and other serious health issues. The rising frequency of hypertension is associated with consuming diets high in salt and processed items, contributing to fluid retention and greater stress on the heart. Losartan potassium assists in managing hypertension by inhibiting angiotensin II, a hormone responsible for constricting blood vessels. This action allows blood vessels to relax and expand, thereby reducing blood pressure and alleviating the heart’s effort. For example, in September 2025, data from the World Health Organization (WHO), a global health authority based in Geneva, Switzerland, indicated that approximately 1.4 billion adults between 30 and 79 years of age had hypertension in 2024, an increase from about 1.3 billion adults in 2022. Consequently, the increasing prevalence of hypertension is propelling the expansion of the losartan potassium active pharmaceutical ingredient (API) market.
Losartan Potassium Active Pharmaceutical Ingredient (API) Market Segment Outlook: Which Categories Are Growing Fastest?
The losartan potassium active pharmaceutical ingredient (api) market covered in this report is segmented –
1) By Product Type: Tablet, Capsule, Other Product Types
2) By Production Method: Synthetic Route, Continuous Flow Production
3) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
4) By Application: Hypertension, Heart Failure, Chronic Kidney Diseases, Other Applications
5) By End-User: Hospitals, Clinics, Pharmaceutical Companies
Subsegments:
1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets, Film-Coated Tablets, Orally Disintegrating Tablets
2) By Capsule: Hard Gelatin Capsules, Modified-Release Capsules
3) By Other Product Types: Bulk Active Pharmaceutical Ingredient (API) Powder, Granules For Suspension, Pre-Formulated Intermediates
Losartan Potassium Active Pharmaceutical Ingredient (API) Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies operating within the losartan potassium active pharmaceutical ingredient (API) market are concentrating on developing innovative products and securing approvals, such as losartan potassium oral suspension, to improve patient compliance and broaden therapeutic applications. Losartan potassium oral suspension is a liquid version of losartan potassium medication, specifically designed for individuals who have difficulty swallowing tablets. For instance, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, obtained Food and Drug Administration (FDA) approval for Arbli. Arbli serves as a ready-to-use liquid formulation for addressing hypertension, reducing the risk of stroke in hypertensive patients with left ventricular hypertrophy, and treating diabetic nephropathy in type 2 diabetes patients. It allows for precise dosing without compounding and is supplied as a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.
Losartan Potassium Active Pharmaceutical Ingredient (API) Market Leading Companies And Competitive Benchmarking
Major companies operating in the losartan potassium active pharmaceutical ingredient (api) market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy’s Laboratories, Cadila Pharmaceuticals Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, IPCA Laboratories Ltd, Alembic Pharmaceuticals Ltd, Granules India Limited, Vasudha Pharma Chem Ltd, IOL Chemicals and Pharmaceuticals Limited, Unichem Laboratories Ltd, Global Pharma Tek, Hetero Drugs Ltd, Manus Aktteva Biopharma LLP, Wellona Pharma, Atom pharma, Sinoway Industrial Co. Ltd, Cerata Pharmaceuticals LLP
View The Full Losartan Potassium Active Pharmaceutical Ingredient (API) Market Report:
Losartan Potassium Active Pharmaceutical Ingredient (API) Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the losartan potassium API market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan potassium active pharmaceutical ingredient (api) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
